Stock Track | Organon & Co Soars 15.99% on Acquisition News by Sun Pharma in $11.75 Billion Deal

Stock Track

Apr 27

Organon & Co. (OGN) shares surged 15.99% during the trading session, following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.

The stock price movement was driven by news that Sun Pharma will acquire Organon in an all-cash transaction valued at approximately $11.75 billion. Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, representing a significant premium to recent trading prices.

The acquisition is expected to enhance Sun Pharma's global footprint, particularly in women's health and biosimilars, while creating a combined entity with projected revenues of about $12.4 billion. The transaction has been approved by the boards of both companies and is anticipated to close in early 2027, subject to regulatory approvals and Organon stockholder consent.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1117297547"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117297547\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117297547?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-27 15:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117297547","market":"nz","top_or_hot":-1,"title":"Stock Track | Organon & Co Soars 15.99% on Acquisition News by Sun Pharma in $11.75 Billion Deal","media":"Stock Track","content":"<p>Organon & Co. (OGN) shares surged 15.99% during the trading session, following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.</p><p>The stock price movement was driven by news that Sun Pharma will acquire Organon in an all-cash transaction valued at approximately $11.75 billion. Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, representing a significant premium to recent trading prices.</p><p>The acquisition is expected to enhance Sun Pharma's global footprint, particularly in women's health and biosimilars, while creating a combined entity with projected revenues of about $12.4 billion. The transaction has been approved by the boards of both companies and is anticipated to close in early 2027, subject to regulatory approvals and Organon stockholder consent.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Organon & Co Soars 15.99% on Acquisition News by Sun Pharma in $11.75 Billion Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Organon & Co Soars 15.99% on Acquisition News by Sun Pharma in $11.75 Billion Deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-27 15:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Organon & Co. (OGN) shares surged 15.99% during the trading session, following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.</p><p>The stock price movement was driven by news that Sun Pharma will acquire Organon in an all-cash transaction valued at approximately $11.75 billion. Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, representing a significant premium to recent trading prices.</p><p>The acquisition is expected to enhance Sun Pharma's global footprint, particularly in women's health and biosimilars, while creating a combined entity with projected revenues of about $12.4 billion. The transaction has been approved by the boards of both companies and is anticipated to close in early 2027, subject to regulatory approvals and Organon stockholder consent.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OGN","symbol_name":"Organon & Co","start_time":0,"source_url":"","article_id":"1117297547","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117297547","pubTimestamp":1777275302,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Organon & Co. (OGN) shares surged 15.99% during the trading session, following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.The stock price movement was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OGN":"Organon & Co"},"translate_title":"个股追踪|Sun Pharma 117.5亿美元收购消息令Organon&Co飙升15.99%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OGN":1},"content_text":"Organon & Co. (OGN) shares surged 15.99% during the trading session, following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.The stock price movement was driven by news that Sun Pharma will acquire Organon in an all-cash transaction valued at approximately $11.75 billion. Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, representing a significant premium to recent trading prices.The acquisition is expected to enhance Sun Pharma's global footprint, particularly in women's health and biosimilars, while creating a combined entity with projected revenues of about $12.4 billion. The transaction has been approved by the boards of both companies and is anticipated to close in early 2027, subject to regulatory approvals and Organon stockholder consent.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}